March 16, 2016 - March 18, 2016

Healthcare Global IPO Review & Recommendations

Dilip Davda and have given "Apply" recommendation to Healthcare Global IPO. recommend to "Avoid" the IPO.

Healthcare Global IPO Review Summary from brokers and analysts

Review By	Apply	May Apply	Neutral	Avoid	Not Rated
Count	2	0	0	1	0
%	66.67	0.00	0.00	33.33	0.00

Healthcare Global IPO Analysis By Brokers/Analysts

Reviewer	Recommendation	Past Reviews
Dilip Davda	Apply
	Avoid
	Apply

Healthcare Global IPO Capital Market Rating

The Captial Market (CapitalMarket.com) rating for Healthcare Global IPO is 40. Their analysis recommends Avoid, however active risk seekers can try for the IPO.

Reviewer	Rating Score	Rating
Capital Market	40	Avoid, however active risk seekers can try

Healthcare Global IPO Review by Dilip Davda (Apply)

[Dilip Davda]

Although the company’s performance has been in negative zone, unique model of Cancer and Fertility treatment under HCG and Milann brands are expected to generate positive earnings in next two to three years. Long term investors may consider investment for adding value on their investment.

Read detail review...

Post Recommendation Manage Recommendations

Note:

The recommendations or analysis of public issues posted above expresses the views of its author and does not represent the views of Chittorgarh.com or its staff.
We reserve the right to remove any objectionable post without providing a reason.